Literature DB >> 9574636

Tumor-related venous obstruction and development of peritumoral brain edema in meningiomas.

M Bitzer1, H Topka, M Morgalla, S Friese, L Wöckel, K Voigt.   

Abstract

OBJECTIVE: The exact pathogenesis of peritumoral brain edema (PTBE) in meningiomas is still unknown. A number of different pathophysiological hypotheses have been considered. A detrimental effect of tumor-related venous obstruction has been suggested as one pathogenetic mechanism. We sought to characterize the significance of venous stasis in the development of PTBE in meningiomas.
METHODS: Angiograms for 134 patients with 136 intracranial meningiomas were analyzed. Pathological changes affecting cortical veins, sylvian veins, bridging veins, deep veins, transmedullary veins, and dural sinuses were evaluated. From preoperative computed tomographic scans, the total tumor volume, the tumor/PTBE volume ratio (edema index [EI]), and the location of the edema were determined. For statistical evaluation, meningiomas associated with pathological venous drainage were compared with size-matched controls.
RESULTS: The edema incidence and the mean EI were not different for meningiomas with unselected signs of obstructed venous drainage, compared with controls. In particular, lesions with involvement of cortical veins, bridging veins, and dural sinuses showed no higher edema incidence. However, meningiomas associated with venous changes in sylvian veins (EI = 4.9 versus EI = 2.7; P < 0.004) and with dysplastic transmedullary veins (EI = 3.3 versus EI = 1.7; P < 0.04) showed significantly higher mean EI values, compared with meningiomas without involvement of these vessels.
CONCLUSION: Our data suggest that tumor-related venous obstruction does not play an essential role in the development of PTBE for the majority of meningiomas. For a small subgroup of meningiomas with involvement of sylvian veins or development of dysplastic transmedullary veins, changes in venous drainage may aggravate preexisting PTBE.

Entities:  

Mesh:

Year:  1998        PMID: 9574636     DOI: 10.1097/00006123-199804000-00026

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

Review 1.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

2.  Secretory meningioma: immunohistochemical findings and evaluation of mast cell infiltration.

Authors:  Wuttipong Tirakotai; Hans-Dieter Mennel; Ilhan Celik; Dieter Hellwig; Helmut Bertalanffy; Thomas Riegel
Journal:  Neurosurg Rev       Date:  2005-07-12       Impact factor: 3.042

3.  Correlation of clinical and biological parameters with peritumoral edema in meningioma.

Authors:  Sun Ha Paek; Chae-Yong Kim; Young Yim Kim; In Ae Park; Min Seok Kim; Dong Gyu Kim; Hee-Won Jung
Journal:  J Neurooncol       Date:  2002-12       Impact factor: 4.130

4.  Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema.

Authors:  Tadashi Osawa; Masahiko Tosaka; Masaya Nagaishi; Yuhei Yoshimoto
Journal:  J Neurooncol       Date:  2012-10-27       Impact factor: 4.130

5.  Radiological classification of meningiomas with hemorrhagic onset and its clinical significance.

Authors:  Zuo-Run Xie; Hong-Cai Wang; Yi-Lei Tong; Shi-Wei Li; Mao-Song Chen; Bo-Ding Wang
Journal:  Oncol Lett       Date:  2022-08-12       Impact factor: 3.111

6.  Three-Dimensional Radiomics Features From Multi-Parameter MRI Combined With Clinical Characteristics Predict Postoperative Cerebral Edema Exacerbation in Patients With Meningioma.

Authors:  Bing Xiao; Yanghua Fan; Zhe Zhang; Zilong Tan; Huan Yang; Wei Tu; Lei Wu; Xiaoli Shen; Hua Guo; Zhen Wu; Xingen Zhu
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

7.  Sphenoid ridge meningioma presenting as acute cerebral infarction.

Authors:  Jun Kyeung Ko; Seung Heon Cha; Chang Hwa Choi
Journal:  J Korean Neurosurg Soc       Date:  2014-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.